The Orphan Drug designation was supported by data from an open-label phase 2 trial that included 8 adult patients with mild to moderate Behçet disease and active oral and/or genital ulcers. The Food ... MarketWatch: Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet's Disease Published in Rheumatology (Oxford) The MarketWatch News Department was not involved in the creation of this content.

Understanding the Context

-- Study results support advancing SGX945 in this difficult-to-treat orphan disease -- Results suggest potential ... Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet's Disease Published in Rheumatology (Oxford) clinicaladvisor.com: Clinical Clustering May Improve Diagnosis and Treatment of Pediatric Behçet Disease Researchers identified 7 distinct phenotypic clusters among pediatric patients with Behçet disease, with manifestations varying based on geography and system involvement. Findings from an ... Pulse Today: Behçet’s disease – what it is and how to spot it Dr Belinda Solomon describes how a case of Behçet’s disease was picked up in her clinic and explains how to recognise and manage this unusual condition ...

Key Insights